Table A2:
CSHRa | 95% CI | p-Value | |
---|---|---|---|
Gender | |||
Female & non-pregnant | 1.000 | - | - |
Female & pregnant | 0.529 | (0.341, 0.820) | 0.004 |
Male | 1.306 | (1.164, 1.465) | <0.001 |
Ageb, per 10 years | 1.110 | (1.035, 1.192) | 0.004 |
CD4b, per 100 cell/μL | 0.663 | (0.608, 0.723) | <0.001 |
HIV status disclosed | 1.072 | (0.914, 1.257) | 0.395 |
Travel time to clinic >30′ | 1.081 | (0.945, 1.235) | 0.256 |
Level of care | |||
Secondary/Tertiary | 1.000 | - | - |
Primary | 0.804 | (0.652, 0.992) | 0.042 |
Cause-specific hazard ratio
At ART initiation